ONO 8713

Drug Profile

ONO 8713

Latest Information Update: 02 Dec 2003

Price : $50

At a glance

  • Originator Ono Pharmaceutical
  • Class Cinnamates
  • Mechanism of Action Prostaglandin E1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Diabetes insipidus; Genitourinary disorders

Most Recent Events

  • 02 Dec 2003 No development reported - Preclinical for Genitourinary disorders in Japan (unspecified route)
  • 02 Dec 2003 No development reported - Preclinical for Diabetes insipidus in Japan (unspecified route)
  • 28 Mar 2001 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top